(AHR) American Healthcare REIT - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock •
AHR: Buildings, Housing, Facilities, Properties, Estates, Healthcare
American Healthcare REIT, Inc. (NYSE:AHR) is a self-managed real estate investment trust that offers investors a unique opportunity to tap into the growing demand for healthcare facilities. By focusing on a diversified portfolio of clinical healthcare properties, including outpatient medical buildings, senior housing, and skilled nursing facilities, AHR positions itself to capitalize on demographic trends such as an aging population and the increasing shift towards outpatient care. This strategic focus allows the company to maintain stable cash flows, a critical factor for REIT investors seeking predictable income.
The companys portfolio is thoughtfully diversified across various healthcare assets, reducing reliance on any single sector. This diversification is particularly advantageous for risk management, as different facilities respond to different market drivers. For instance, senior housing demand is closely tied to demographic changes, while outpatient centers are influenced by healthcare utilization patterns. Such a balanced approach can mitigate risks associated with market fluctuations in individual sectors.
From a financial standpoint, AHRs market capitalization of approximately $4.48 billion underscores its significant presence in the healthcare REIT sector. The price-to-book (P/B) ratio of 2.03 and price-to-sales (P/S) ratio of 2.24 provide insights into the companys valuation. The P/B ratio suggests that investors are valuing the companys assets at twice their book value, indicating confidence in the asset quality. The P/S ratio, meanwhile, reflects the premium investors are placing on the companys revenue generation capabilities, which is crucial for assessing its growth potential.
Geographic diversification is another key strength, with properties spanning 36 states in the U.S., as well as international locations in the UK and Isle of Man. This broad reach helps mitigate regional risks, such as local economic downturns or regulatory changes, enhancing the overall stability of the investment. For investors seeking exposure to healthcare real estate with minimized geographic risk, this diversification
Additional Sources for AHR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AHR Stock Overview
Market Cap in USD | 4,702m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2024-02-07 |
AHR Stock Ratings
Growth 5y | 52.8% |
Fundamental | 10.7% |
Dividend | 24.9% |
Rel. Strength | 101 |
Analysts | 4.25/5 |
Fair Price Momentum | 33.71 USD |
Fair Price DCF | 12.34 USD |
AHR Dividends
Dividend Yield 12m | 3.62% |
Yield on Cost 5y | 8.05% |
Annual Growth 5y | -50.00% |
Payout Consistency | 100.0% |
AHR Growth Ratios
Growth Correlation 3m | 70.1% |
Growth Correlation 12m | 97.4% |
Growth Correlation 5y | 97.7% |
CAGR 5y | 119.80% |
CAGR/Max DD 5y | 10.10 |
Sharpe Ratio 12m | 3.74 |
Alpha | 121.20 |
Beta | 0.806 |
Volatility | 28.58% |
Current Volume | 2157.6k |
Average Volume 20d | 2011.5k |
As of April 03, 2025, the stock is trading at USD 30.79 with a total of 2,157,643 shares traded.
Over the past week, the price has changed by +4.04%, over one month by +1.99%, over three months by +11.87% and over the past year by +128.17%.
Neither. Based on ValueRay Fundamental Analyses, American Healthcare REIT is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AHR as of April 2025 is 33.71. This means that AHR is currently overvalued and has a potential downside of 9.48%.
American Healthcare REIT has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy AHR.
- Strong Buy: 3
- Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AHR American Healthcare REIT will be worth about 37.1 in April 2026. The stock is currently trading at 30.79. This means that the stock has a potential upside of +20.33%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 33.9 | 10% |
Analysts Target Price | 31.1 | 1.1% |
ValueRay Target Price | 37.1 | 20.3% |